BSE: ZYDUSLIFE - Zydus Lifesciences Limited

Rentabilité sur six mois: -8.83%
Secteur: Healthcare

Calendrier des promotions Zydus Lifesciences Limited


À propos de l'entreprise

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, Latin America, the Asia Pacific, and Africa. The company operates in Pharmaceuticals and Consumer Products segments.

plus de détails
It offers finished dosage human formulations comprising generics, branded generics, and specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; and products in the therapeutic areas of pain management, neurology, dermatology, liver diseases, and other areas. The company also provides consumer wellness products, such as Complan; EverYuth, a range of skincare products; Nycil; Glucon-D glucose powder; Nutralite; Nutralite Doodhshakti, a portfolio of dairy products; and various other products. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, ophthalmology, inflammation, rheumatology, hepatology, infectious disease, etc. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is based in Ahmedabad, India.

EBITDA 25.16
EV/EBITDA 14.03
ISIN INE010B01027
Industry Pharmaceuticals
P/BV 2.4
P/E 23.93
P/S 2.04
Sector Health Care
Валюта inr
Валюта отчета inr
Выручка 138.12
Див.доход ао 1.34
Дивиденд ао 6
Сайт https://zyduslife.com
Цена ао 1054.35
Число акций ао 1.0122 млрд
Changement de prix par jour: +1.37% (959.55)
Changement de prix par semaine: -0.1232% (973.9)
Changement de prix par mois: +2.31% (950.7)
Changement de prix sur 3 mois: -9.48% (1074.6)
Changement de prix sur six mois: -8.83% (1066.95)
Changement de prix par an: +41.75% (686.2)
Evolution du prix sur 3 ans: +119.03% (444.1)
Evolution du prix sur 5 ans: +332.98% (224.65)
Evolution des prix sur 10 ans: 0% (972.7)
Evolution des prix depuis le début de l'année: -1.55% (988)

Sous-estimation

Nom Signification Grade
P/S 5.29 2
P/BV 4.55 3
P/E 26.06 6
EV/EBITDA 14.65 7
Total: 5

Efficacité

Nom Signification Grade
ROA, % 14.03 4
ROE, % 20.67 7
Total: 4.17

Dividendes

Nom Signification Grade
Div yield, % 0.7249 1.8
DSI 0.8571 8.57
Total: 2.58

Devoir

Nom Signification Grade
Debt/EBITDA 0 10
Total: 10

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 37.72 5
Rentabilité Ebitda, % 36.84 5
Rentabilité EPS, % 233.73 10
Total: 7.2



Superviseur Titre d'emploi Paiement Année de naissance
Dr. Sharvil Pankajbhai Patel MD & Executive Director 262.5M 1979 (46 années)
Dr. Ganesh Narayan Nayak COO & Executive Director 120M 1955 (70 années)
Mr. Punit Patel President & CEO of America N/A
Mr. Nitinkumar Dalsukhray Parekh Chief Financial Officer 54.31M
Mr. Arvind Bothra Head of Investor Relations N/A
Mr. Dhaval Narendra Soni Company Secretary & Compliance Officer 2.09M

Adresse: India, Ahmedabad, Zydus Corporate Park - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://zyduslife.com